Mitigating the impact of antibacterial drug resistance through host-directed therapies: current progress, outlook, and challenges
CY Chiang, I Uzoma, RT Moore, M Gilbert… - MBio, 2018 - Am Soc Microbiol
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
[HTML][HTML] Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
CY Chiang, I Uzoma, RT Moore, M Gilbert… - mBio, 2018 - ncbi.nlm.nih.gov
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
[PDF][PDF] Mitigating the impact of antibacterial drug resistance through host-directed therapies: current progress, outlook, and challenges. mBio 9: e01932-17
CY Chiang, I Uzoma, RT Moore, M Gilbert… - 2018 - researchgate.net
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
CY Chiang, I Uzoma, RT Moore, M Gilbert… - 2018 - agris.fao.org
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges
CY Chiang, I Uzoma, RT Moore, M Gilbert… - mBio, 2018 - pubmed.ncbi.nlm.nih.gov
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.
CY Chiang, I Uzoma, RT Moore, M Gilbert… - Mbio, 2018 - europepmc.org
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …
Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.
CY Chiang, I Uzoma, RT Moore, M Gilbert… - Mbio, 2018 - europepmc.org
Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to
treat and manage bacterial infection. The development and FDA approval of novel …
treat and manage bacterial infection. The development and FDA approval of novel …